These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26829287)

  • 1. Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis.
    Gupta A; Misra A; Deretic V
    Adv Drug Deliv Rev; 2016 Jul; 102():10-20. PubMed ID: 26829287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection.
    Mohareer K; Asalla S; Banerjee S
    Tuberculosis (Edinb); 2018 Dec; 113():99-121. PubMed ID: 30514519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalable Particles for "Pincer Therapeutics" Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of Tuberculosis.
    Gupta A; Meena J; Sharma D; Gupta P; Gupta UD; Kumar S; Sharma S; Panda AK; Misra A
    Mol Pharm; 2016 Sep; 13(9):3247-55. PubMed ID: 27463245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.
    Gupta A; Sharma D; Meena J; Pandya S; Sachan M; Kumar S; Singh K; Mitra K; Sharma S; Panda AK; Gupta P; Gupta UD; Misra A
    Pharm Res; 2016 Aug; 33(8):1899-912. PubMed ID: 27095353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled drug therapy for treatment of tuberculosis.
    Misra A; Hickey AJ; Rossi C; Borchard G; Terada H; Makino K; Fourie PB; Colombo P
    Tuberculosis (Edinb); 2011 Jan; 91(1):71-81. PubMed ID: 20875771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of host-pathogen modulators of autophagy during Mycobacterium Tuberculosis infection and therapeutic repercussions.
    Khan A; Jagannath C
    Int Rev Immunol; 2017 Sep; 36(5):271-286. PubMed ID: 28976784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Macrophage Response to
    Maphasa RE; Meyer M; Dube A
    Front Cell Infect Microbiol; 2020; 10():618414. PubMed ID: 33628745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold Nanorods as Drug Delivery Vehicles for Rifampicin Greatly Improve the Efficacy of Combating Mycobacterium tuberculosis with Good Biocompatibility with the Host Cells.
    Ali HR; Ali MR; Wu Y; Selim SA; Abdelaal HF; Nasr EA; El-Sayed MA
    Bioconjug Chem; 2016 Oct; 27(10):2486-2492. PubMed ID: 27595304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalable particles containing rapamycin for induction of autophagy in macrophages infected with Mycobacterium tuberculosis.
    Gupta A; Pant G; Mitra K; Madan J; Chourasia MK; Misra A
    Mol Pharm; 2014 Apr; 11(4):1201-7. PubMed ID: 24533458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
    Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
    Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-23a-5p modulates mycobacterial survival and autophagy during mycobacterium tuberculosis infection through TLR2/MyD88/NF-κB pathway by targeting TLR2.
    Gu X; Gao Y; Mu DG; Fu EQ
    Exp Cell Res; 2017 May; 354(2):71-77. PubMed ID: 28327409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.
    Niu NK; Yin JJ; Yang YX; Wang ZL; Zhou ZW; He ZX; Chen XW; Zhang X; Duan W; Yang T; Zhou SF
    Drug Des Devel Ther; 2015; 9():4441-70. PubMed ID: 26300629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reclaiming hijacked phagosomes: Hybrid nano-in-micro encapsulated MIAP peptide ensures host directed therapy by specifically augmenting phagosome-maturation and apoptosis in TB infected macrophage cells.
    Sharma A; Vaghasiya K; Gupta P; Gupta UD; Verma RK
    Int J Pharm; 2018 Jan; 536(1):50-62. PubMed ID: 29180254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy in the fight against tuberculosis.
    Bento CF; Empadinhas N; Mendes V
    DNA Cell Biol; 2015 Apr; 34(4):228-42. PubMed ID: 25607549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis.
    Shen P; Li Q; Ma J; Tian M; Hong F; Zhai X; Li J; Huang H; Shi C
    BMC Microbiol; 2017 Aug; 17(1):185. PubMed ID: 28835201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Vesicles Released from
    Alvarez-Jiménez VD; Leyva-Paredes K; García-Martínez M; Vázquez-Flores L; García-Paredes VG; Campillo-Navarro M; Romo-Cruz I; Rosales-García VH; Castañeda-Casimiro J; González-Pozos S; Hernández JM; Wong-Baeza C; García-Pérez BE; Ortiz-Navarrete V; Estrada-Parra S; Serafín-López J; Wong-Baeza I; Chacón-Salinas R; Estrada-García I
    Front Immunol; 2018; 9():272. PubMed ID: 29520273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.
    Garg T; Goyal AK; Rath G; Murthy RS
    Pharm Dev Technol; 2016 Dec; 21(8):951-960. PubMed ID: 26334961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.